Some researchers inject daily with much lower doses (e.g., 1 to 2 mg per day instead of 7 mg weekly)
Several limitations should be considered
After reconstitution, store at 28C and use within the recommended period
Retatrutide, with its triple action on GLP-1, GIP, and glucagon receptors, is the most advanced example yet
If you used semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) for weight loss and did not see good changes, there may be another option for you
A different non-insulin injectable diabetes medication Victoza (liraglutide) was approved in 2010, but in 2013, the FDA issued a warning to consumers of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas. And this first warning isnt an anomaly